1. Targeted variant prevalence of FBXW7 gene mutation in colorectal carcinoma propagation. The first systematic review and meta-analysis
   Hafeez Abiola Afolabi et al, 2024, Heliyon CrossRef
2. Predictive potential of angiopoietin-2 in a mCRC subpopulation treated with vanucizumab in the McCAVE trial
   Cláudia S. Ferreira et al, 2023, Frontiers in Oncology CrossRef
3. A Group of Tumor-Suppressive micro-RNAs Changes Expression Coordinately in Colon Cancer
   Ovidiu Farc et al, 2023, Current Issues in Molecular Biology CrossRef
4. The Role of KRAS Mutation in Colorectal Cancer-Associated Thrombosis
   Radu Andrei Emilescu et al, 2023, International Journal of Molecular Sciences CrossRef
5. Optimizing the number of variants tracked to follow disease burden with circulating tumor DNA assays in metastatic colorectal cancer
   Mélina Boutin et al, 2023, Therapeutic Advances in Medical Oncology CrossRef
6. The current understanding on the impact of KRAS on colorectal cancer
   Mingjing Meng et al, 2021, Biomedicine & Pharmacotherapy CrossRef
7. ATF6 supports lysosomal function in tumor cells to enable ER stress-activated macroautophagy and CMA: impact on mutant TP53 expression
   Rossella Benedetti et al, 2024, Autophagy CrossRef
8. Inhibition of angiogenesis and metastasis in colorectal cancer cell lines through KRAS-associated signaling pathways by 2-methoxy-6-undecyl-1,4-benzoquinone
   Noor Izzah Abd Rahman et al, 2024, Chemico-Biological Interactions CrossRef
9. Canadian Consensus Recommendations on the Management of KRAS G12C-Mutated NSCLC
   Parneet K. Cheema et al, 2023, Current Oncology CrossRef
10. The emerging era of personalized medicine in advanced colorectal cancer
    Claudia W K Wu et al, 2022, Journal of Gastroenterology and Hepatology CrossRef
11. Mixed large cell neuroendocrine carcinoma and squamous cell carcinoma of the colon: detailed molecular characterisation of two cases indicates a distinct colorectal cancer entity
    Christine Woischke et al, 2021, The Journal of Pathology: Clinical Research CrossRef
12. Genomic landscape and survival analysis of ctDNA “neo-RAS wild-type” patients with originally RAS mutant metastatic colorectal cancer
    Chiara Nicolazzo et al, 2023, Frontiers in Oncology CrossRef
13. Targeting Metastatic Colorectal Cancer with Immune Oncological Therapies
    Norman J. Galbraith et al, 2021, Cancers CrossRef
14. Detecting colorectal cancer using genetic and epigenetic biomarkers: screening and diagnosis
    Muhammad Miftahussurur et al, 2024, Journal of Medicine and Life CrossRef
15. Pancreatic cancer driver mutations are targetable through distant alternative RNA splicing dependencies
    Ryan R. Kawalerski et al, 2021, Oncotarget CrossRef
16. An Early-Onset Advanced Rectal Cancer Patient With Increased KRAS Gene Copy Number Showed A Primary Resistance to Cetuximab in Combination With Chemotherapy: A Case Report
    Tian Fang et al, 2021, Frontiers in Oncology CrossRef
17. Murine models of colorectal cancer: the azoxymethane (AOM)/dextran sulfate sodium (DSS) model of colitis-associated cancer
    Dzhuliia Dzhalilova et al, 2023, PeerJ CrossRef
18. Synonymous Variants: Necessary Nuance in Our Understanding of Cancer Drivers and Treatment Outcomes
    Nayiri M Kaissarian et al, 2022, JNCI: Journal of the National Cancer Institute CrossRef
19. RETRACTED: Targeted delivery of 5-fluorouracil, miR-532-3p, and si-KRAS to the colorectal tumor using layer-by-layer liposomes
    Maryamsadat Shahidi et al, 2022, Frontiers in Bioengineering and Biotechnology CrossRef